利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

18 条记录 (耗时 0.015 秒)

    SYSTEM AND METHOD FOR REDUCING PULSATILE PRESSURE
    4.
    发明申请
    SYSTEM AND METHOD FOR REDUCING PULSATILE PRESSURE 审中-公开

    公开(公告)号：US20200368507A1

    公开(公告)日：2020-11-26

    申请号：US16989830

    申请日：2020-08-10

    申请人： Aria CV, Inc.

    发明人： John SCANDURRA ,  Karl VOLLMERS

    IPC分类号： A61M29/02 ,  A61M1/10 ,  A61M25/04

    摘要： A device for reducing pressure within a lumen includes a reservoir structured for holding a fluid therein, an injection port in fluid communication with the reservoir, a compliant body structured to expand and contract upon changes in pressure, and a conduit extending between and fluidly coupling the reservoir and the compliant body. The fluid may be a compressible or a noncompressible fluid.

    SYSTEMS AND METHODS FOR TREATING PULMONARY HYPERTENSION
    7.
    发明申请
    SYSTEMS AND METHODS FOR TREATING PULMONARY HYPERTENSION 审中-公开

    公开(公告)号：US20200306435A1

    公开(公告)日：2020-10-01

    申请号：US16900794

    申请日：2020-06-12

    申请人： Aria CV, Inc.

    发明人： Karl VOLLMERS ,  John SCANDURRA

    IPC分类号： A61M1/10 ,  A61M25/10 ,  A61M39/02 ,  A61M5/172 ,  A61B17/12 ,  A61M5/50 ,  A61M25/04 ,  A61M25/06 ,  A61M29/02 ,  A61M1/12

    摘要： A system for treating heart disease, such as pulmonary hypertension or right heart failure, including an implantable component and external components for monitoring the implantable component is provided. The implantable component may include a compliant member, e.g., balloon, coupled to a reservoir via a conduit. Preferably, the compliant member is adapted to be implanted in a pulmonary artery and the reservoir is adapted to be implanted subcutaneously. The external components may include a clinical controller component, monitoring software configured to run a clinician's computer, a patient monitoring device, and a mobile application configured to run on a patient's mobile device.

    SYSTEMS AND METHODS FOR TREATING PULMONARY HYPERTENSION
    8.
    发明申请
    SYSTEMS AND METHODS FOR TREATING PULMONARY HYPERTENSION 审中-公开

    公开(公告)号：US20180036464A1

    公开(公告)日：2018-02-08

    申请号：US15785304

    申请日：2017-10-16

    申请人： Aria CV, Inc.

    发明人： Karl VOLLMERS ,  John SCANDURRA

    IPC分类号： A61M1/10 ,  A61M39/02 ,  A61M25/04 ,  A61M1/12 ,  A61M5/172

    摘要： A system for treating heart disease, such as pulmonary hypertension or right heart failure, including an implantable component and external components for monitoring the implantable component is provided. The implantable component may include a compliant member, e.g., balloon, coupled to a reservoir via a conduit. Preferably, the compliant member is adapted to be implanted in a pulmonary artery and the reservoir is adapted to be implanted subcutaneously. The external components may include a clinical controller component, monitoring software configured to run a clinician's computer, a patient monitoring device, and a mobile application configured to run on a patient's mobile device.

    DIFFUSION AND INFUSION RESISTANT IMPLANTABLE DEVICES FOR REDUCING PULSATILE PRESSURE
    10.
    发明申请
    DIFFUSION AND INFUSION RESISTANT IMPLANTABLE DEVICES FOR REDUCING PULSATILE PRESSURE 有权

    公开(公告)号：US20210069396A1

    公开(公告)日：2021-03-11

    申请号：US17011870

    申请日：2020-09-03

    申请人： Aria CV, Inc.

    发明人： Karl VOLLMERS ,  Lynn ZWIERS ,  John GAINOR ,  John SCANDURRA

    IPC分类号： A61M1/10 ,  A61M1/12 ,  C01B17/45

    摘要： Diffusion and infusion resistant implantable devices and methods for reducing pulsatile pressure are provided. The implantable device includes a balloon implantable within a blood vessel of a patient, e.g., the pulmonary artery. The balloon is injected with a fluid mixture comprising a constituent fluid(s) and a diffusion-resistant gas to provide optimal balloon volume and limit fluid diffusion throughout multiple cardiac cycles. The fluid mixture may be pressurized such that the balloon is transitionable between an expanded state and a collapsed state responsive to pressure fluctuations in the blood vessel.